Literature DB >> 21999840

Milk in the diet: good or bad for vascular disease?

D I Givens1.   

Abstract

CVD still represent the greatest cause of death and disease burden in Europe and there remains uncertainty whether or not diets rich in milk and/or dairy products affect CVD risk. This paper reviews current evidence on this from prospective studies and the role of serum lipids and blood pressure as markers of CVD risk with such diets. Also the potential of animal nutrition-based approaches aimed at reducing CVD risk from consumption of milk and dairy products is outlined. Briefly, the evidence from prospective studies indicates that increased consumption of milk does not result in increased CVD risk and may give some long-term benefits, although few studies relate specifically to cheese and butter and more information on the relationship between milk/dairy product consumption and dementia is needed. Recent data suggest that the SFA in dairy products may be less of a risk factor than previously thought; although this is based on serum cholesterol responses which taken in isolation may be misleading. Milk and some dairy products have counterbalancing effects by reducing blood pressure and possibly BMI control. Despite this, animal nutrition strategies to replace some SFA in milk with cis-MUFA or cis-PUFA are extensive and intuitively beneficial, although this remains largely unproven, especially for milk. There is an urgent need for robust intervention studies to evaluate such milk-fat modifications using holistic markers of CVD risk including central arterial stiffness.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21999840     DOI: 10.1017/S0029665111003223

Source DB:  PubMed          Journal:  Proc Nutr Soc        ISSN: 0029-6651            Impact factor:   6.297


  8 in total

Review 1.  Effects of dairy protein and fat on the metabolic syndrome and type 2 diabetes.

Authors:  Ann Bjørnshave; Kjeld Hermansen
Journal:  Rev Diabet Stud       Date:  2014-08-10

2.  Relations between dairy food intake and arterial stiffness: pulse wave velocity and pulse pressure.

Authors:  Georgina E Crichton; Merrrill F Elias; Gregory A Dore; Walter P Abhayaratna; Michael A Robbins
Journal:  Hypertension       Date:  2012-03-19       Impact factor: 10.190

3.  Associations of dietary intake patterns identified using reduced rank regression with markers of arterial stiffness among youth with type 1 diabetes.

Authors:  A P Lamichhane; A D Liese; E M Urbina; J L Crandell; L M Jaacks; D Dabelea; M H Black; A T Merchant; E J Mayer-Davis
Journal:  Eur J Clin Nutr       Date:  2014-05-28       Impact factor: 4.016

4.  Dietary lipid intake only partially influences variance in serum phospholipid fatty acid composition in adolescents: impact of other dietary factors.

Authors:  Krishna Vyncke; Inge Huybrechts; Myriam Van Winckel; Magdalena Cuenca Garcia; Idoia Labayen; Frederic Gottrand; Kurt Widhalm; Catherine Leclercq; Lars Libuda; Yannis Manios; Michael Sjostrom; Denes Molnar; Luis A Moreno; Marcela Gonzalez-Gross; André Spinneker; Fatima Perez de Heredia; Maria Plada; Stefaan De Henauw
Journal:  Lipids       Date:  2014-08-14       Impact factor: 1.880

Review 5.  Calcium supplementation: is protecting against osteoporosis counter to protecting against cardiovascular disease?

Authors:  Connie M Weaver
Journal:  Curr Osteoporos Rep       Date:  2014-06       Impact factor: 5.096

Review 6.  Dairy and cardiovascular health: Friend or foe?

Authors:  O Markey; D Vasilopoulou; D I Givens; J A Lovegrove
Journal:  Nutr Bull       Date:  2014-06

Review 7.  Role of Fatty Acids in Milk Fat and the Influence of Selected Factors on Their Variability-A Review.

Authors:  Oto Hanuš; Eva Samková; Ludmila Křížová; Lucie Hasoňová; Robert Kala
Journal:  Molecules       Date:  2018-07-04       Impact factor: 4.411

Review 8.  Milk consumption and multiple health outcomes: umbrella review of systematic reviews and meta-analyses in humans.

Authors:  Xingxia Zhang; Xinrong Chen; Yujie Xu; Jie Yang; Liang Du; Ka Li; Yong Zhou
Journal:  Nutr Metab (Lond)       Date:  2021-01-07       Impact factor: 4.169

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.